Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Dysrhythmias IV: Characteristics of Bradyarrhythmias

Dysrhythmias IV: Characteristics of Bradyarrhythmias

Bradyarrhythmias are cardiac rhythm disorders characterized by a slower-than-normal heart rate, typically defined as fewer than 60 beats per minute. Some of which are discussed here:Sinus BradycardiaSinus bradycardia presents a heart rate lower than 60 beats per minute, with a regular rhythm originating from the SA node. The ECG typically shows normal P waves preceding each QRS complex, a normal PR interval (0.12 to 0.20 seconds), and a normal QRS duration (0.06 to 0.10 seconds).First-Degree AV...

Mechanism of Cardiac Arrhythmias

Mechanism of Cardiac Arrhythmias

Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.

Cardiac Action Potential

Cardiac Action Potential

Cardiac action potentials are essential for proper heart function, enabling the rhythmic contractions needed for adequate blood circulation. Nodal cells and Purkinje fibers, specialized for electrical conduction, generate these action potentials.
The cardiac action potential process involves a series of phases characterized by the movement of ions across the cardiac cell membranes, leading to the depolarization and repolarization of the cardiac myocytes.
Ionic Basis of Cardiac Action Potentials

Dysrhythmias III: Characteristics of Dysrhythmias

Dysrhythmias III: Characteristics of Dysrhythmias

Dysrhythmias, also known as arrhythmias, are irregular heart rhythms that result from abnormal electrical activity in the heart, affecting its ability to circulate blood efficiently. Tachyarrhythmias, a subset of dysrhythmias, are characterized by abnormally fast heart rates exceeding 100 beats per minute. Here are some types of tachyarrhythmias with their distinct ECG features:Sinus Tachycardia:Sinus tachycardia presents a regular heart rhythm with an increased rate of 101-180 beats per...

Acute Coronary Syndrome III: Diagnostic Studies

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...

Dysrhythmias I: Introduction

Dysrhythmias I: Introduction

Dysrhythmias refers to abnormalities in the heart's rhythm. They result from disruptions in the heart's electrical conduction system, which includes the sinoatrial(SA)node, atrioventricular(AV) node, the bundle of His, bundle branches, and Purkinje fibers.Definition and PathophysiologyDysrhythmias result from disorders of impulse formation, impulse conduction, or both. The heart contains specialized cells in the sinoatrial node, atrioventricular node, and the bundle of His and Purkinje fibers...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Deep venous thrombosis following placement of temporary hemodialysis catheters in patients with end-stage renal disease.

Clinical nephrology·2025

Same author

Cerebellar Ataxia With Neuropathy and Bilateral Vestibular Areflexia Syndrome Coexisting With JAK2-Positive Polycythemia Vera and Myelofibrosis.

Ochsner journal·2025

Same author

Etiology and Outcomes in Patients With Chronic Kidney Disease and Ascites.

Cureus·2024

Same author

Incidence, Risk Factors and Prognosis of Hypokalaemia in Patients with Normokalaemia at Hospital Admission.

Indian journal of endocrinology and metabolism·2024

Same author

Thyroid Dysfunction in Patients with and Without Venous Thromboembolism: a Case Control Study.

Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion·2023

Same author

The First Differentiated TB Care Model From India: Delays and Predictors of Losses in the Care Cascade.

Global health, science and practice·2023

Search research articles

Related Experiment Video

Updated: Feb 21, 2026

Dual-Dye Optical Mapping of Hearts from RyR2R2474S Knock-In Mice of Catecholaminergic Polymorphic Ventricular Tachycardia

Dual-Dye Optical Mapping of Hearts from RyR2R2474S Knock-In Mice of Catecholaminergic Polymorphic Ventricular Tachycardia

Published on: December 22, 2023

Yellow phosphorus-induced Brugada phenocopy.

Mayakrishnan Dharanipradab¹, Stalin Viswanathan¹, Gokula Raman Kumar¹

¹Department of General Medicine, Indira Gandhi Medical College & Research Institute, Kathirkamam, Pondicherry 605009, India.

Journal of Electrocardiology

|October 9, 2017

Summary

This summary is machine-generated.

Yellow phosphorus poisoning can cause Brugada phenocopy, a heart rhythm abnormality. This case highlights a rare cardiac complication of yellow phosphorus ingestion, distinct from metallic phosphide toxicity.

Keywords:

Brugada phenocopy Brugada syndrome Brugada-type ECG pattern Phosphide Yellow phosphorus poisoning

More Related Videos

Local Field Fluorescence Microscopy: Imaging Cellular Signals in Intact Hearts

Local Field Fluorescence Microscopy: Imaging Cellular Signals in Intact Hearts

Published on: March 8, 2017

Microelectrode Array Recording of Sinoatrial Node Firing Rate to Identify Intrinsic Cardiac Pacemaking Defects in Mice

Microelectrode Array Recording of Sinoatrial Node Firing Rate to Identify Intrinsic Cardiac Pacemaking Defects in Mice

Published on: July 5, 2021

Related Experiment Videos

Last Updated: Feb 21, 2026

Dual-Dye Optical Mapping of Hearts from RyR2R2474S Knock-In Mice of Catecholaminergic Polymorphic Ventricular Tachycardia

Dual-Dye Optical Mapping of Hearts from RyR2R2474S Knock-In Mice of Catecholaminergic Polymorphic Ventricular Tachycardia

Published on: December 22, 2023

Local Field Fluorescence Microscopy: Imaging Cellular Signals in Intact Hearts

Local Field Fluorescence Microscopy: Imaging Cellular Signals in Intact Hearts

Published on: March 8, 2017

Microelectrode Array Recording of Sinoatrial Node Firing Rate to Identify Intrinsic Cardiac Pacemaking Defects in Mice

Microelectrode Array Recording of Sinoatrial Node Firing Rate to Identify Intrinsic Cardiac Pacemaking Defects in Mice

Published on: July 5, 2021

Area of Science:

Toxicology
Cardiology
Emergency Medicine

Background:

Yellow phosphorus and metallic phosphides are common rodenticides in developing nations.
Yellow phosphorus toxicity primarily affects the liver, kidneys, heart, pancreas, and brain.
Cardiotoxicity, including Brugada ECG patterns, is documented with metallic phosphide poisoning.

Observation:

A 29-year-old male presented with Brugada phenocopy and hepatic dysfunction after ingesting yellow phosphorus.
Electrocardiogram revealed type 1 and type 2 Brugada patterns, resolving spontaneously within three days.
The patient experienced no hemodynamic compromise or malignant arrhythmias.

Findings:

This is the first reported case of yellow phosphorus-induced Brugada phenocopy.
The cardiac manifestation occurred without severe hemodynamic compromise.
The Brugada patterns resolved spontaneously, indicating a potentially reversible cardiotoxic effect.

Implications:

Yellow phosphorus ingestion should be considered a potential cause of Brugada phenocopy.
Early recognition and monitoring are crucial for managing yellow phosphorus poisoning.
This finding expands the understanding of cardiotoxicity associated with phosphorus compounds.